Literature DB >> 32777780

Spinal Seeding Metastasis of Myxopapillary Ependymoma: Report of Three Pediatric Patients and a Brief Literature Review.

Anas Abdallah1.   

Abstract

OBJECTIVE: Myxopapillary ependymomas (MPEs) in children are rarely reported low-grade glial tumors; however, MPEs sometimes possess malignant characteristics such as spinal seeding/drop metastasis (SSM). We aimed to present 3 pediatric MPE cases that experienced SSM at 2 neurosurgical centers.
MATERIALS AND METHODS: We retrospectively reviewed the medical records of 38 primary spinal MPE cases who underwent surgery at 2 neurosurgical centers spanning 16 years, from 2004 to 2019. All pediatric cases (patient age <18 years) who were diagnosed with MPE and re-presented with SSM were selected as the core sample for this study. Relevant literature was briefly reviewed.
RESULTS: Three pediatric MPE cases (2 females and 1 male) experienced SSM. The mean age at first presentation was 12.0 ± 1.0 years. The mean preoperative course was 2.9 ± 1.2 months. The predominant location was the lumbar spine in 2 tumors (both originated from terminal filum [TF]). Two tumors were located intradural intramedullary. Gross-total resection was achieved in 2 patients. No patient had neurofibromatosis type 2. No adjuvant treatment was given after the first surgery. The mean period between the first diagnosis and diagnosis of SSM was 44.0 ± 31.5 months. The location of SSM in all patients was the sacral spine (1 patient experienced distant metastasis in her brain besides her sacral metastasis). The mean follow-up was 68.3 ± 53.7 months.
CONCLUSIONS: We found a statistically significant relationship between SSM in pediatric MPEs and the intramedullary location, TF origin, and number of affected segments. Close clinical and radiological follow-up is essential for pediatric MPE patients.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Gross-total resection; Myxopapillary ependymoma; Seeding metastasis

Mesh:

Year:  2020        PMID: 32777780     DOI: 10.1159/000509061

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  1 in total

1.  Multi-modality imaging and therapeutics used in a case of canine spinal nephroblastoma.

Authors:  Powell T Slinkard; Susan E Lana; Chad B Frank; Lynn R Griffin
Journal:  Can Vet J       Date:  2022-08       Impact factor: 1.075

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.